Groups of 80 male and female F344 rats were exposed by gavage to ochratoxin A, a naturally occurring mycotoxin, at levels of 21, 70, and 210 μg/kg body weight for up to 2 years. Ochratoxin A induced nonneoplastic renal tubular epithelial changes consisting of cytoplasmic alteration, karyomegaly, degeneration, and cysts. Exposure-related renal tubular proliferative lesions included focal hyperplasia, tubular cell adenoma, and tubular cell carcinoma. Renal tubular cell adenoma occurred as early as 9 months in 1 high-dose male rat, and both adenomas and carcinomas were seen in males by 15 months. At the terminal sacrifice, renal tubular cell tumors were found in both male and female rats, but the response was more pronounced in the males. The incidence of renal tumors in the high-dose rats was the highest of any National Toxicology Program (NTP) study completed to date. In the high-dose males approximately one-third of the renal carcinomas developed metastases. This study demonstrates that ochratoxin A is a potent renal carcinogen in the F344 rat and suggests that contamination of feedstuff by this mycotoxin may pose a potential hazard to domestic animals and man.
1. Aleo MD, Wyatt RD, and Schnellmann RG (1991). Mitochondrial dysfunction is an early event in ochratoxin A but not oosporein toxicity to rat renal proximal tubules. Toxicol. Appl. Pharmacol107: 73–80.
2.
2. Bannasch Pand Zerban H (1986). Renal cell adenoma and carcinoma, rat. In: Monographs on Pathology of Laboratory Animals, Urinary System, TC Jones, U Mohr, and RD Hunt (eds). Springer-Verlag, New York, pp. 112–138.
3.
3. Bendele AM, Carlton WW, Krogh P, and Lillehoj EB (1985). Ochratoxin A carcinogenesis in the (C57BL/6J × C3H)F1 mouse. J. Natl. Cancer Inst75: 733–742.
4.
4. Bendele AM, Neal SB, Oberly TJ, Thompson CZ, Bewsey BJ, Hill LE, Rexroat MA, Carlton WW, and Probst GS (1985). Evaluation of ochratoxin A for mutagenicity in a battery of bacterial and mammalian cell assays. Food Chem. Toxicol23: 911–918.
5.
5. Boorman GA and Eustis SL (1985). The pathology working group as a means for assuring pathology quality in toxicological studies. In: Managing Conduct and Data Quality of Toxicology Studies, BK Hoover, JK Baldwin, AF Uelner, CE Whitmire, CL Davies, and DW Bristol (eds). Princeton Scientific Publishing Co., Inc., Princeton, NJ, pp. 271–276.
6.
6. Boorman GA, Hong HL, Dieter MP, Hayes HT, Pohland AE, Stack M, and Luster MI (1984). Myelotoxicity and macrophage alteration in mice exposed to ochratoxin A. Toxicol. Appl. Pharmacol72: 304–312.
7.
7. Boorman GA, Montgomery CA Jr, Eustis SL, Wolfe MJ, McConnell EE, and Hardisty JF (1985). Quality assurance in pathology for rodent carcinogenicity studies. In: Handbook of Carcinogen Testing, H Milman and E Weisburger (eds). Noyes Publishers, Park Ridge, NJ, pp. 345–357.
8.
8. Bprghoff SJ, Short BG, and Swenberg JA (1990). Biochemical meohanisms and pathobiology of alpha 2uglobulin nephropathy. Annu. Rev. Pharmacol. Toxicol30: 349–367.
9.
9. Brown MH, Szczech GM, and Purmalis BP (1976). Teratogenic and toxic effects of ochratoxin A in rats. Toxicol. Appl. Pharmacol37: 331–338.
10.
10. Castegnaro M, Bartsch H, and Chemozemsky l (1987). Endemic nephropathy and urinary tract tumors in the Balkans. (Meeting report.)Cancer Res47: 3608–3609.
11.
11. Chang FC and Chu FC (1977). The fate of ochratoxin A in rats. Food Cosmet. Toxicol15: 199–204.
12.
12. Creppy EE, Kane A, Dirheimer G, Lafarge-Frayssinet C, Mousset S, and Frayssinet C (1985). Gcnotoxicity of ochratoxin A in mice: DNA single-strand break evaluation in spleen, liver and kidney. Toxicol. Lett28: 29–35.
13.
13. Endo H (1983). Effect of ochratoxin A on enzyme release from isolated nephron segments in rats. (In Japanese.)Proc. Jpn. Assoc. Mycotoxicol18: 21–28.
14.
14. Hayes AW, Hood RD, and Lee HL (1974). Teratogenic effects of ochratoxin A in mice. Teratology9: 93–97.
15.
15. Hard GC and Butler WH (1971). Morphogenesis of epithelial neoplasms induced in the rat kidney by dimethylnitrosamine. Cancer Res31: 1496–1505.
16.
16. International Agency for Research on Cancer (IARC) (1976). Ochratoxin A. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Some naturally occurring substances, Vol. 10. IARC, Lyon, France, pp. 191–197.
17.
17. Kanisawa M (1984). Synergistic effect of citrinin on hepatorenal carcinogenesis of ochratoxin A in mice. In: Toxigenic Fungi, Their Toxins and Health Hazard, H Kurata and Y Ueno (eds). Elsevier/North Holland, Amsterdam, pp. 245–254.
18.
18. Kanisawa M and Suzuki S (1978). Induction of renal and hepatic tumors in mice by ochratoxin A, a mycotoxin. Gann69: 599–600.
19.
19. Kuiper-Goodman T (1990). Uncertainties in the risk assessment of three mycotoxins: Aflatoxin, ochratoxin and zearalenone. Can. J. Physical. Pharmacol68: 1017–1024.
20.
20. Luster MI, Germolec DR, Burleson GR, Jameson CW, Ackermann MF, Lamm KR, and Hayes HT (1987). Selective immunosuppression in mice of natural killer cell activity by ochratoxin A. Cancer Res47: 2259–2263.
21.
21. Marquardt RR, Frohlich A, and Abramson D (1990). Ochratoxin A: An important western Canadian storage mycotoxin. Can. J. Physiol. Pharmacol68: 991–999.
22.
22. Meisner H and Cimbala M (1986). Effect of ochratoxin A on gene expression in rat kidneys. Dev. Toxicol. Environ. Sci12: 261–271.
23.
23. National Toxicology Program (NTP) (1987). Toxicology and carcinogenesis studies of bromodichlo-romethane (CAS No. 75–27–4) in F344 rats and B6C3F1 mice. Technical Report No. 321, US Department of Health and Human Services, Public Health Service, NIH, NIEHS, Research Triangle Park, NC.
24.
24. National Toxicology Program (NTP) (1987). Toxicology and carcinogenesis studies of 1,4-dichlorobenzene (CAS No. 106–46–7) in F344 rats and B6C3F1 mice. Technical Report No. 319, US Department of Health and Human Services, Public Health Service, NIH, NIEHS, Research Triangle Park, NC.
25.
25. National Toxicology Program (NTP) (1989). Toxicology and carcinogenesis studies of hexachloroethane (CAS No. 67–72–1) in F344 rats. Technical Report No. 361, US Department of Health and Human Services, Public Health Service, NIH, NIEHS, Research Triangle Park, NC.
26.
26. National Toxicology Program (NTP) (1990). Carcinogenesis studies of D-limonene (CAS No. 5989–27–5) in F344 rats and B6C3F1 mice. Technical Report No. 347, US Department of Health and Human Services, Public Health Service, NIH, NIEHS, Research Triangle Park, NC.
27.
27. National Toxicology Program (NTP) (1989). Toxicology and carcinogenesis studies of 8-methoxypsoralen (CAS No. 298–81–7) in F344 rats. Technical Report No. 359, US Department of Health and Human Services, Public Health Service, NIH, NIEHS, Research Triangle Park, NC.
28.
28. National Toxicology Program (NTP) (1988). Toxicology and carcinogenesis studies of monuron (CAS No. 150–68–5) in F344 rats. Technical Report No. 358, US Department of Health and Human Services, Public Health Service, NIH, NIEHS, Research Triangle Park, NC.
29.
29. National Toxicology Program (NTP) (1989). Toxicology and carcinogenesis studies of nitrofurantoin (CAS No. 67–20–9) in F344 rats and B6C3F1 mice. Technical Report No. 341, US Department of Health and Human Services, Public Health Service, NIH, NIEHS, Research Triangle Park, NC.
30.
30. National Toxicology Program (NTP) (1989). Toxicology and carcinogenesis studies of ochratoxin A (CAS No. 303–47–9) in F344 rats. Technical Report No. 359, US Department of Health and Human Services, Public Health Service, NIH, NIEHS, Research Triangle Park, NC.
31.
31. National Toxicology Program (NTP) (1991). Toxicology and carcinogenesis studies of quercetin (CAS No. 117–39–5) in F344 rats. Technical Report No. 359, US Department of Health and Human Services, Public Health Service, NIH, NIEHS, Research Triangle Park, NC.
32.
32. National Toxicology Program (NTP) (1986). Toxicology and carcinogenesis studies of tetrachloroethylene (perchloroethylene) (CAS No. 127–18–4) in F344 rats and B6C3F1 mice. Technical Report No. 311, US Department of Health and Human Services, Public Health Service, NIH, NIEHS, Research Triangle Park, NC.
33.
33. National Toxicology Program (NTP) (1990). Toxicology and carcinogenesis studies of trichloroethylene (without epichlorohydrin) (CAS No. 79–01–6) in F344 rats and B6C3F1 mice. Technical Report No. 243, US Department of Health and Human Services, Public Health Service, NIH, NIEHS, Research Triangle Park, NC.
34.
34. National Toxicology Program (NTP) (1990). Toxicology and carcinogenesis studies of tris (2-chloroethyl) phosphate (CAS No. 115–96–8) in F344 rats and B6C3F1 mice. Technical Report No. 391, US Department of Health and Human Services, Public Health Service, NIH, NIEHS, Research Triangle Park, NC.
35.
35. NIH Guide for the Care and Use of Laboratory Animals (1985). US Department of Health and Human Services, Public Health Service, NIH publication No. 85–23, NIH, Bethesda, MD.
36.
36. Nyska A, Waner T, Pirak M, Gordon E, Bracha P, and Klein B (1989). The renal carcinogenic effect of merpafol in the Fischer 344 rat. Isr. J. Med. Sci25: 428–432.
37.
37. Plestina R, Ceovic S, Gatenbeck S, Habazin-Novak VH, Kult K, Hokby E, Krogh P, and Radic B (1990). Human exposure to ochratoxin A in areas of Yugoslavia with endemic nephropathy. J. Environ. Pathol. Toxicol. Oncol10: 145–148.
38.
38. Purchase IFH and Theron JJ (1968). The acute toxicity of ochratoxin A to rats. Food Cos/net. Toxicol6: 479–483.
39.
39. Purchase IFH and van der Watt JJ (1971). The long-term toxicity of ochratoxin to rats. Food Cosmet. Toxicol9: 681–682.
40.
40. Storen O, Holm H, and Stormer FC (1982). Metabolism of ochratoxin A by rats. Appl. Environ. Microbiol44: 785–789.
41.
41. Steyn AF and Holzapfel CW (1967). Synthesis of ochratoxin A and B. Metabolites of Aspergillus ochraceus. Tetrahedron23: 4449–4461.
42.
42. Tanner DC and Lipsky MM (1984). Effect of lead acetate on N-(4'-fluoro-4-biphenyl) acetamide-induced renal carcinogenesis in the rat. Carcinogenesis5: 1109–1113.
43.
43. Ueno Y (1985). The toxicology of mycotoxins. CRC Crit. Rev. Toxicol14: 99–132.
44.
44. Van Der Merwe KJ, Steyn PS, and Fourie L (1965). Mycotoxins. II. The constitutions of ochratoxins A, B, and C, metabolites of Aspergillus ochraceus. J. Chem. Soc5: 7083–7088.
